Vericel Corporation

Form 483 issued July 21, 2023 · Cambridge, Massachusetts

Inspection
Jul 13 – Jul 21, 2023
Investigator
Nancy L. Neiger
Observations
7
Pages
7
FEI number
3002836339

In short: On July 21, 2023, FDA issued a Form 483 with 7 observations to Vericel Corporation in Cambridge, Massachusetts (FEI 3002836339) after an inspection that ran Jul 13 – Jul 21, 2023. The investigator was Nancy L. Neiger. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment2
Production2
Laboratory controls1
Quality system1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce…

  2. 02

    Written procedures are not followed that describe the examinations to be conducted on appropriate samples of…

  3. 03

    Aseptic processing areas are deficient regarding the system…

  4. 04

    Acceptance criteria for the sampling and testing conducted by the quality control unit is not adequate…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Vericel Corporation?

FDA listed 7 observations on this Form 483, mostly about facilities & equipment, production and laboratory controls. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Vericel Corporation?

Nancy L. Neiger is named on this Form 483, for the inspection of Jul 13 – Jul 21, 2023. Each investigator has a profile showing what they cite most.

When was Vericel Corporation inspected by FDA?

The inspection ran Jul 13 – Jul 21, 2023, and the Form 483 is dated July 21, 2023.

How do I get the full Form 483 for Vericel Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free